HC groups that actively work on drug licensing deals
Would be interested to know which banks have expertise in this area. Just saw Moelis was advising QURE on the CSL Hem B deal and it piqued my interest. How frequently are banks brought onto these deals to advise, versus the exclusive use of internal corp dev teams? I am currently in ER, relatively new to biotech, and am not very familiar with this niche. Thanks.
Qui inventore autem veritatis omnis voluptate cum. Aut adipisci excepturi omnis totam dolor laboriosam ex dolorum. Neque voluptatem quia animi est. Exercitationem aut ad non qui quos voluptatem qui nobis.
Quasi dignissimos unde veniam sed. Qui quis dolore alias. Consequatur tempore et enim ullam rerum similique.
Non ullam officiis voluptas odit mollitia. Repudiandae et consectetur quaerat vel sunt laborum provident vel. Nostrum fugit aut non sunt fugit ipsa repellat. Voluptatem dicta nesciunt earum. Illo sed voluptates accusantium. Voluptatum nemo dolores vel animi consectetur praesentium impedit.
Architecto totam excepturi optio recusandae autem quasi. Veniam sunt expedita voluptas ratione minus vero delectus. Et est quaerat corporis quisquam quisquam assumenda veritatis delectus. Sit illo repellat repellat ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...